Trial Profile
Clinical Trials Insight: 700013093
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Feb 2010
Price :
$35
*
At a glance
- Drugs INCB 9471 (Primary)
- Indications HIV infections
- Focus Adverse reactions
- Sponsors Incyte Corporation
- 25 May 2006 New trial record.